Pluri Inc.
Nasdaq: PLUR
——
The chart fills in as daily closes arrive.
52-week range — – —
End-of-day prices. Not live quotes, and not investment advice.
Funding and exits
No funding round or acquisition of Pluri Inc. has been reported on this site yet.
Pluri Inc. in the news
No business news about Pluri Inc. yet.
More in Pharma & biotech
| Company | Industry | Listed | Close | Day | Market value |
|---|---|---|---|---|---|
| BioLineRx Ltd. | Pharma & biotech | Nasdaq: BLRX | — | — | — |
| Can-Fite BioPharma Ltd. | Pharma & biotech | NYSE: CANF | — | — | — |
| Chemomab Therapeutics Ltd. | Pharma & biotech | Nasdaq: CMMB | — | — | — |
| Compugen Ltd. | Pharma & biotech | Nasdaq: CGEN | — | — | — |
| Enlivex Ltd. | Pharma & biotech | Nasdaq: ENLV | — | — | — |
| Entera Bio Ltd. | Pharma & biotech | Nasdaq: ENTX | — | — | — |